Leila is an infectious disease epidemiologist who joined Burnet in 2021 to start a PhD through Monash University. The aims of her project are to inform the strengthening of sustainable and effective surveillance for hepatitis B prevention, diagnosis, and management in the Pacific, with a focus on Vanuatu. The outcomes of this research will add to the understanding of the hepatitis B burden to guide public health prioritisation, as well as support reporting against global and regional strategies. Leila has also supported Burnet's ACCESS Myanmar pilot as a research assistant.
Prior to joining Burnet, Leila worked with the World Health Organization Health Emergencies Programmes at the regional office for the Western Pacific (WPRO) in Manila, Philippines. During her time at WPRO, Leila's work was mostly focused on outbreak surveillance and response.
BMC Public Health
Zeshi Fisher, Leila Bell, Aleesha Kalulu, Kali Ameara, Caroline Homer, Caroline van Gemert, Leila Bell, Aleesha Kalulu, Kali Ameara, Zeshi Fisher
BMC Public Health
Zeshi Fisher, Leila Bell, Aleesha Kalulu, Kali Ameara, Caroline Homer, Caroline van Gemert, Leila Bell, Aleesha Kalulu, Kali Ameara, Zeshi Fisher
The Lancet Regional Health - Western Pacific
Leila Bell, Caroline van Gemert, Margaret Hellard, Caroline Homer, Jess Howell
We're working with partners to see how the 7-1-7 approach can help track and respond to disease outbreaks in the Pacific.
We offer a range of studies focusing on prevention of mother-to-child transmission of hepatitis B.
This field trial compares the effectiveness of WHO-based viral load testing guidelines to an alternative model of care.